Use of hormonal contraceptives and risk of HIV-1 transmission

The Lancet Infectious Diseases

Volumn 12, Issue 7, 2012, Pages 507-508

  Shelton, James D ^a  

^a UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ORAL CONTRACEPTIVE AGENT;

COITUS; CONDOM; CONTRACEPTION; DISEASE TRANSMISSION; FAMILY PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RATE; INFECTION RISK; LETTER; PREGNANCY RATE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NOTE;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE;

EID: 84862736230     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70112-3     Document Type: Letter

References (5)

1. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012, 12:19-26.
2. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011, 3:77ra29.
3. Tanton C, Weiss HA, Le Goff J, et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One 2011, 6:e17480.
4. Aklilu M, Messele T, Tsegaye A, et al. Factors associated with HIV-1 infection among sex workers of Addis Abab, Ethiopia. AIDS 2001, 15:87-96.
5. Boily M-C, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009, 9:118-129.